Daptomycin

BreastfeedingGeriatricPediatric
  • TRADE NAME: Cubicin (Cubist)
  • INDICATIONS: Complicated skin and skin structure infections, Staphylococcus aureus bloodstream infections
  • CLASS: Antibiotic, glycopeptide
  • HALF-LIFE: ~8 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:

Atorvastatin, Cyclosporine, Fibrates, HMG-CoA reductase inhibitors, Rosuvastatin, Statins, Tobramycin, Typhoid Vaccine, Warfarin

PREGNANCY CATEGORY: B

Our database has 67 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
MUCOSAL
CARDIOVASCULAR
CENTRAL NERVOUS SYSTEM
ENDOCRINE/METABOLIC
GASTROINTESTINAL/HEPATIC
GENITOURINARY
HEMATOLOGIC
LOCAL
NEUROMUSCULAR/SKELETAL
OCULAR
RENAL
RESPIRATORY
OTHER


Page last updated 11/08/2018

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric
^ Back to top